Therapeutic Activity of High-Dose Intratumoral IFN-β Requires Direct Effect on the Tumor Vasculature-Reference-Cited by-同舟云学术

Therapeutic Activity of High-Dose Intratumoral IFN-β Requires Direct Effect on the Tumor Vasculature

Published:2014-09-12 Issue:8 Volume:193 Page:4254-4260
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Spaapen Robbert M.,Leung Michael Y. K.,Fuertes Mercedes B.,Kline Justin P.,Zhang Long,Zheng Yan,Fu Yang-Xin,Luo Xixi,Cohen Kenneth S.,Gajewski Thomas F.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference38 articles.

1. Cytokine therapeutics: lessons from interferon alpha.

2. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.;Kirkwood;J. Clin. Oncol.,1996

3. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells

4. Type I interferon is selectively required by dendritic cells for immune rejection of tumors

5. Type I interferon response and innate immune sensing of cancer

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ORMDL3 restrains type-I interferon signaling and anti-tumor immunity by promoting RIG-I degradation;2024-08-13

2. GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunity;Oncogene;2024-07-27

3. Enhancing antitumor immunity and achieving tumor eradication with IL11RA mRNA immunotherapy;International Immunopharmacology;2024-06

4. Targeting inflammation as cancer therapy;Journal of Hematology & Oncology;2024-03-22

5. GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunity;2024-02-23